Design of potential reverse transcriptase inhibitor containing Isatin nucleus using molecular modeling studies

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 9, 2010, Pages 3198-3211

  Pawar, Vidya ^a   Lokwani, Deepak ^a   Bhandari, Shashikant ^a   Mitra, Debashis ^b   Sabde, Sudeep ^b   Bothara, Kailash ^c   Madgulkar, Ashwini ^a  

^a AISSMS COLLEGE OF PHARMACY   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

^c School of Pharmacy and Technology Management   (India)

Author keywords

Docking; Isatin; QSAR; Reverse transcriptase inhibitor

Indexed keywords

3 (4H 1,2,4 TRIAZOL 4 YLIMINO) 1 [(DIMETHYLAMINO) METHYL] 5 METHYLINDOLIN 2 ONE; 3 (4H 1,2,4 TRIAZOL 4 YLIMINO) 5 METHYL 1 (MORPHOLINOMETHYL) INDOLIN 2 ONE; 3 (4H 1,2,4 TRIAZOL 4 YLIMINO) 5 METHYL 1 [(PIPERAZIN 1 YL) METHYL] INDOLIN 2 ONE; 3 (4H 1,2,4 TRIAZOL 4 YLIMINO) 5 METHYL 1 [(PIPERIDIN 1 YL) METHYL] INDOLIN 2 ONE; 3 (4H 1,2,4 TRIAZOL 4 YLIMINO) 5 METHYL 1 [METHYL(PHENYL)AMINO] INDOLIN 2 ONE; 5 METHYL ISATIN; DELAVIRDINE; EFAVIRENZ; ISATIN DERIVATIVE; ISONITROSOACETOP TOLUIDINE; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROGEN BOND; INFORMATION PROCESSING; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SCORING SYSTEM; STRUCTURE ANALYSIS;

AMINOPYRIDINES; DRUG DESIGN; HIV-1; HUMANS; IMINO ACIDS; ISATIN; MODELS, MOLECULAR; MODELS, STATISTICAL; MOLECULAR STRUCTURE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 77951296058     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2010.03.030     Document Type: Article

References (28)

1. Gottlieb M.S., Schro R., Schankar H.M., Weisman J.D., Fan P.T., Wolf R.A., and Saxon A. N. Eng. J. Med. 305 (1981) 1425
2. Barre Sinoussi F., Chermann J.C., Rey F., Nugeyre M.T., and Chamart S. Science 220 (1983) 868
3. Balzarini J. Curr. Top. Med. Chem. 4 (2004) 921
4. Daisley R.W., and Shah V.K. J. Pharm. Sci. 73 (1984) 407
5. Varma R.S., and Nobles W.L. J. Med. Chem. 10 (1967) 972
6. Piscapo B., Dium M.V., Godliardi R., Cucciniello M., and Veneruso G. Bol. Soc. Ital. Biol. Sper. 63 (1987) 827
7. Pandeya S.N., Sriram D., Nath G., and DeClercq E. Eur. J. Pharm. Sci. 9 (1999) 25
8. Pandeya S.N., Sriram D., Nath G., and Clercq D. Arzneim.-Forsch. 50 (2000) 55
9. Bhattacharya S.K., and Chakraborti A. Indian J. Exp. Biol. 36 (1998) 118
10. Sriram D., Bal T.R., and Yogeeswari P. IL Farmaco 60 (2005) 377
11. Boechat N., Kover W.B., Bastos M.M., Romeiro N.C., Silva A.S.C., Santos F.C., Valverde A.L., Azevedo M.L.G., Wollinger W., Souza T.M.L., Souza S., and de Frugulhetti P.P. Med. Chem. Res. 15 (2007) 492
12. Sriram D., Bal T.R., and Yogeeswari P. J. Pharm. Pharm. Sci. 8 (2005) 565
13. Schiifer W., Friebe W., Leinert H., Mertens A., Poll T., Saal W., Zilch H., Nuber B., and Zieglertsf M.L. J. Med. Chem. 36 (1993) 726
14. Ragno R., Frasca S., Manetti F., Brizzi A., and Massa S. J. Med. Chem. 48 (2005) 200
15. VLife MDS 3.5, Molecular Design Suite, Vlife Sciences Technologies Pvt. Ltd., Pune, India, 2004. (www.vlifesciences.com).
16. glide, Molecular Docking Tool of Schrodinger Inc., version 5.0, New York, USA.
17. Meclellan L.M., Sokol L.M., and Kontoyiamn M. J. Med. Chem. 47 (2004) 558
18. QikProp, Version 3.0, Schrodinger, LLC, New York, NY, 2005.
19. Sriram D., Bal T., and Yogeeswari P. Bioorg. Med. Chem. 12 (2004) 5865
20. Pandeya S.N., Dhamrajan S., Nath G., and Claercq E. Eur. J. Med. Chem. 35 (2000) 249
21. Hudson B.D., Rahr R.M., Wood J., and Osman J. Quant. Struct.-Act. Relat. 15 (1996) 285
22. Sharaf M.A., Illman D.L., and Kowalski B.R. Chemometrics (1986), Wiley, New York
23. Jorgensen L., Maxwell D., and Tirado-Rives J. J. Am. Chem. Soc. 118 (1996) 11225
24. Hayes M.J., Stein M., and Weiser J. J. Phys. Chem. 108 (2004) 3572
25. Friesner R.A., Murphy R.B., Repasky M.P., Frye L.L., Greenwood J.R., Halgren T.A., Sanschagrin P.C., and Mainz D.T. J. Med. Chem. 49 (2006) 6177
26. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P.J. Adv. Drug Delivery Rev. 23 (1997) 3
27. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P.J. Adv. Drug Delivery Rev. 46 (2001) 3
28. Gilman H., Jeremiah P., and Gilman H. In: Wayland E. (Ed). Organic Syntheses Coll. Vol. 1 (1941), Wiley & Sons, Noland 327